Panagora Asset Management Inc Intellia Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$20.02 - $27.22 $355,314 - $483,100	17,748 New	17,748 $397,000
Q1 2022 May 12, 2022	SELL	$58.27 - $118.99 $101,331 - $206,923	-1,739 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$100.76 - $138.36 $4,433 - $6,087	-44 Reduced 2.47%	1,739 $206,000
Q2 2021 Aug 11, 2021	SELL	$60.88 - $161.91 $5,966 - $15,867	-98 Reduced 5.21%	1,783 $289,000
Q1 2021 May 12, 2021	BUY	$46.59 - $83.68 $78,876 - $141,670	1,693 Added 900.53%	1,881 $151,000
Q4 2020 Feb 10, 2021	BUY	$18.83 - $63.53 $3,540 - $11,943	188 New	188 $10,000

316

91.7M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.